Down-regulated miR-9 and miR-433 in human gastric carcinoma
about
Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencingPotential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric CancerRAS-MAPK pathway epigenetic activation in cancer: miRNAs in actionThe role of endocytic Rab GTPases in regulation of growth factor signaling and the migration and invasion of tumor cellsClinical application of microRNA in gastric cancer in Eastern Asian areaMicroRNAs in autophagy and their emerging roles in crosstalk with apoptosisRole of miRNAs and their potential to be useful as diagnostic and prognostic biomarkers in gastric cancerMicroRNA-433 inhibits cell proliferation in hepatocellular carcinoma by targeting p21 activated kinase (PAK4)The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesisHsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinomaRoles of differential expression of microRNA-21-3p and microRNA-433 in FSH regulation in rat anterior pituitary cells.MiRNA as potential biomarkers and therapeutic targets for gastric cancer.Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis.MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2.MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma.MicroRNA-9 as potential biomarker for breast cancer local recurrence and tumor estrogen receptor statusPathogenetic mechanisms in gastric cancer.Antagonism pattern detection between microRNA and target expression in Ewing's sarcoma.MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer.Tumor-microenvironment interactions studied by zonal transcriptional profiling of squamous cell lung carcinoma.microRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1.MicroRNA profile of paclitaxel-resistant serous ovarian carcinoma based on formalin-fixed paraffin-embedded samples.MicroRNA-433 negatively regulates the expression of thymidylate synthase (TYMS) responsible for 5-fluorouracil sensitivity in HeLa cells.MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma.A systematic review of microRNA expression profiling studies in human gastric cancer.MicroRNA-9 as a novel prognostic biomarker in human laryngeal squamous cell carcinoma.The role of microRNAs in nasopharyngeal carcinoma.miR-200b inhibits prostate cancer EMT, growth and metastasisMicroRNA-545 suppresses cell proliferation by targeting cyclin D1 and CDK4 in lung cancer cellsMicroRNAs in renal fibrosis.Potentially predictive microRNAs of gastric cancer with metastasis to lymph node.Silencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomasAberrant hypermethylation of miR-9 genes in gastric cancer.MicroRNA-9: functional evolution of a conserved small regulatory RNA.Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells.The GALNT9, BNC1 and CCDC8 genes are frequently epigenetically dysregulated in breast tumours that metastasise to the brainMethylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas.MicroRNA 433 regulates nonsense-mediated mRNA decay by targeting SMG5 mRNA.The role of microRNAs in Helicobacter pylori pathogenesis and gastric carcinogenesis.MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells.
P2860
Q21134708-0E493CCB-58AE-42C4-8025-B3EF407C01BDQ26744362-F816B925-DB0B-4E68-9BC3-72434586A8B3Q26773479-03EEF4B4-9529-4892-B920-7B0CE4786761Q26796377-D9B15E93-E2F8-4027-A28C-0D16BAA34281Q26829583-5C941F8B-0EA3-4361-8B63-700EC1B9C9DFQ27008099-0F82DA9A-7896-44D0-8272-FFDD112FF9EBQ28067449-9B15838F-2D81-4751-8BCD-D0A073E27C15Q28251819-8C31EDFD-D801-4E17-BCD6-C38084B6763CQ28271675-60984BD4-2AAB-490A-A476-1E3BF489B0D1Q28289487-0AAE95CD-95A4-4B6F-ABD4-F39CDF491A75Q33829561-CF67D1A7-6BB2-4A58-AFBA-CD82D4E0A326Q34036679-49FEC207-CBD2-48C1-8C1C-F4C6AFB6EEDAQ34089030-C3DEAE60-36E1-45D6-9B71-46341BDFFBE8Q34120830-18628379-4929-4869-90A3-86D88B89A915Q34256676-CBF1BBA0-DAE9-453E-BE1B-A96C38ADD43EQ34314082-854EB7ED-9F1A-4673-9A9C-2C5D9FB32D4DQ34326627-056EDB9F-2522-40E8-A0AD-27256CFF0A93Q34358973-392AC0BC-8C0F-46C9-8400-51D7360D5070Q34423582-7349B55C-246E-4D9A-9BAB-7A2C11C98330Q34449094-A2C1CC4C-1FEC-40A7-8CB9-062525CE3E83Q34576919-0FB6E3E5-61FB-491A-A5CB-935A89A0F3CCQ34694027-D2AA2B2B-834D-4393-8156-1F73C71B3CE1Q34894800-3FA189E9-DB97-4A4E-AD83-78A5807359D2Q34956599-377B8FA4-D386-44A4-BC62-4AA212C981D9Q35000434-858BBE83-96BB-49CB-AE2E-5BF9C0F10E3DQ35017255-9B6E854E-05C0-4822-9598-47C98D7E03CCQ35043716-DCA67D98-E144-48AD-8764-9D70E3FEA3EEQ35082717-46F85CC3-F723-42E8-AB7C-27F4D541073FQ35088400-2308413B-84A3-4839-B801-B5266A5E4CECQ35104478-92429680-9038-4B08-AA40-AEA201E71E1CQ35232213-DD95085B-1D57-4DEF-ADD5-D058C12737F5Q35235761-BD779546-5A2C-4BFE-BE79-89870BCE7DE6Q35578002-C5C9EF1E-9DB1-4883-8ED1-7FDB2966BBECQ35578530-E02882C8-811B-449E-988A-258DEE61D377Q35602152-61BDAF3E-1ADD-4E03-850E-DCE99CD0E641Q35687321-069ED495-05B7-425B-9FF0-FDC606E416A7Q35792884-3AC99C02-D254-4D23-8B3D-4C275253B9B3Q36090334-6BBA5152-895E-41EA-BFFD-CD387565B34DQ36158807-20D9AC22-33DC-4B84-8BAE-0501426F46C7Q36215852-48038F50-899C-4220-8253-193EEB53E38D
P2860
Down-regulated miR-9 and miR-433 in human gastric carcinoma
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Down-regulated miR-9 and miR-433 in human gastric carcinoma
@ast
Down-regulated miR-9 and miR-433 in human gastric carcinoma
@en
Down-regulated miR-9 and miR-433 in human gastric carcinoma
@en-gb
Down-regulated miR-9 and miR-433 in human gastric carcinoma
@nl
type
label
Down-regulated miR-9 and miR-433 in human gastric carcinoma
@ast
Down-regulated miR-9 and miR-433 in human gastric carcinoma
@en
Down-regulated miR-9 and miR-433 in human gastric carcinoma
@en-gb
Down-regulated miR-9 and miR-433 in human gastric carcinoma
@nl
prefLabel
Down-regulated miR-9 and miR-433 in human gastric carcinoma
@ast
Down-regulated miR-9 and miR-433 in human gastric carcinoma
@en
Down-regulated miR-9 and miR-433 in human gastric carcinoma
@en-gb
Down-regulated miR-9 and miR-433 in human gastric carcinoma
@nl
P2093
P2860
P3181
P356
P1476
Down-regulated miR-9 and miR-433 in human gastric carcinoma
@en
P2093
Hongbin Zhang
Hongchun Luo
Jinjun Guo
Xiaoling Wu
Zhenzhen Zhang
P2860
P2888
P3181
P356
10.1186/1756-9966-28-82
P407
P577
2009-01-01T00:00:00Z
P5875
P6179
1035081058